Literature DB >> 29291650

Hypoglycemia in Hospitalized Hemodialysis Patients With Diabetes: An Observational Study.

Roma Y Gianchandani1, Shristi Neupane1, Michael Heung2.   

Abstract

INTRODUCTION: Hypoglycemia and hyperglycemia affect outcomes in hospitalized patient. Patients with diabetes and end stage renal disease are prone to hypoglycemia and few studies have evaluated glucometrics to identify the incidence and risk factors for hypoglycemia in this population.
METHODS: We designed an observational retrospective review of 150 insulin requiring inpatients with diabetes receiving hemodialysis. We collected demographics, baseline characteristics, and glucometric data focusing on episodes of hypoglycemia with glucose cutoffs <70, <54, and <40 mg/dl. Detailed glucose and insulin data for 24 hours before and after hemodialysis was analyzed for each patient in context of a hypoglycemic episode. T-tests, one-way ANOVA, and chi-square tests were used for statistical analysis.
RESULTS: At least one glucose value less than 70 mg/dl was observed in 51% of hemodialysis patients, less than 54 mg/dl in 28%, and less than 40 mg/dl in 11%. Patients with hypoglycemia had a higher HbA1c, standard deviation of glucose ( P = .0009) and higher total daily dose (TDD) of insulin by weight (0.34 units/kg vs 0.23 units/kg, P = .003). We observed a linear increasing risk for hypoglycemia with increasing TDD, with nearly 65% of hypoglycemic episodes occurring with TDD >0.20 units/kg. A majority (61%) of all hypoglycemic episodes occurred in the 24 hours prior to a hemodialysis session. Type 1 diabetes was independently associated with hypoglycemia.
CONCLUSIONS: Hospitalized diabetes patients undergoing hemodialysis were found to have high rates of hypoglycemia. Our results support using a lower TDD of insulin in this population (<0.23 units/kg/day) and recommend special caution in those with type 1 diabetes.

Entities:  

Keywords:  diabetes; end stage renal disease; hemodialysis; hypoglycemia; insulin

Mesh:

Substances:

Year:  2018        PMID: 29291650      PMCID: PMC5761994          DOI: 10.1177/1932296817747620

Source DB:  PubMed          Journal:  J Diabetes Sci Technol        ISSN: 1932-2968


  21 in total

Review 1.  Glucose and insulin metabolism in uremia.

Authors:  R H Mak; R A DeFronzo
Journal:  Nephron       Date:  1992       Impact factor: 2.847

2.  Analysis of hemodialysis-associated hypoglycemia in patients with type 2 diabetes using a continuous glucose monitoring system.

Authors:  Hye Seung Jung; Hong Il Kim; Min Joo Kim; Ji Won Yoon; Hwa Young Ahn; Young Min Cho; Kook-Hwan Oh; Kwon Wook Joo; Jung Geon Lee; Seong Yeon Kim; Kyong Soo Park
Journal:  Diabetes Technol Ther       Date:  2010-10       Impact factor: 6.118

3.  Hypoglycemia-associated mortality is not drug-associated but linked to comorbidities.

Authors:  Laura Boucai; William N Southern; Joel Zonszein
Journal:  Am J Med       Date:  2011-11       Impact factor: 4.965

Review 4.  Glucose Concentrations of Less Than 3.0 mmol/L (54 mg/dL) Should Be Reported in Clinical Trials: A Joint Position Statement of the American Diabetes Association and the European Association for the Study of Diabetes.

Authors: 
Journal:  Diabetes Care       Date:  2016-11-21       Impact factor: 19.112

5.  The association between hyperglycaemia on admission and 180-day mortality in acute myocardial infarction patients with and without diabetes.

Authors:  T Ainla; A Baburin; R Teesalu; M Rahu
Journal:  Diabet Med       Date:  2005-10       Impact factor: 4.359

6.  Association between hyperglycemia and increased hospital mortality in a heterogeneous population of critically ill patients.

Authors:  James Stephen Krinsley
Journal:  Mayo Clin Proc       Date:  2003-12       Impact factor: 7.616

7.  Day-to-day variation of insulin requirements of patients with type 2 diabetes and end-stage renal disease undergoing maintenance hemodialysis.

Authors:  Eugene Sobngwi; Sostanie Enoru; Gloria Ashuntantang; Marcel Azabji-Kenfack; Mesmin Dehayem; Arnold Onana; Daniel Biwole; François Kaze; Jean-François Gautier; Jean-Claude Mbanya
Journal:  Diabetes Care       Date:  2010-03-09       Impact factor: 17.152

8.  Hypoglycemia in diabetic patients undergoing chronic hemodialysis.

Authors:  Chiao-Yin Sun; Chin-Chan Lee; Mai-Szu Wu
Journal:  Ther Apher Dial       Date:  2009-04       Impact factor: 1.762

Review 9.  Intensive insulin therapy and mortality among critically ill patients: a meta-analysis including NICE-SUGAR study data.

Authors:  Donald E G Griesdale; Russell J de Souza; Rob M van Dam; Daren K Heyland; Deborah J Cook; Atul Malhotra; Rupinder Dhaliwal; William R Henderson; Dean R Chittock; Simon Finfer; Daniel Talmor
Journal:  CMAJ       Date:  2009-03-24       Impact factor: 8.262

10.  Weight-based, insulin dose-related hypoglycemia in hospitalized patients with diabetes.

Authors:  Daniel J Rubin; Denis Rybin; Gheorghe Doros; Marie E McDonnell
Journal:  Diabetes Care       Date:  2011-06-23       Impact factor: 19.112

View more
  5 in total

Review 1.  Inpatient Glycemic Management in the Setting of Renal Insufficiency/Failure/Dialysis.

Authors:  Ravi Iyengar; Jennifer Franzese; Roma Gianchandani
Journal:  Curr Diab Rep       Date:  2018-08-15       Impact factor: 4.810

2.  Hypoglycemic and Hyperglycemic Crises Among U.S. Adults With Diabetes and End-stage Kidney Disease: Population-Based Study, 2013-2017.

Authors:  Rodolfo J Galindo; Mohammed K Ali; Shealeigh A Funni; Andrew B Dodge; Shaheen S Kurani; Nilay D Shah; Guillermo E Umpierrez; Rozalina G McCoy
Journal:  Diabetes Care       Date:  2022-01-01       Impact factor: 17.152

Review 3.  Glycemic Monitoring and Management in Advanced Chronic Kidney Disease.

Authors:  Rodolfo J Galindo; Roy W Beck; Maria F Scioscia; Guillermo E Umpierrez; Katherine R Tuttle
Journal:  Endocr Rev       Date:  2020-10-01       Impact factor: 19.871

Review 4.  The risk factors of inpatient hypoglycemia: A systematic review.

Authors:  Chici Pratiwi; Muhammad Ikhsan Mokoagow; Ida Ayu Made Kshanti; Pradana Soewondo
Journal:  Heliyon       Date:  2020-05-11

5.  Pioglitazone Is Associated with Lower Major Adverse Cardiovascular and Cerebrovascular Events than DPP4-Inhibitors in Diabetic Patients with End-Stage Renal Disease: A Taiwan Nationwide Cohort Study, 2006-2016.

Authors:  Min-Hao Lin; Huang-Yu Yang; Chieh-Li Yen; Chao-Yi Wu; Chang-Chyi Jenq; George Kuo; Wei-Sheng Peng; Jia-Rou Liu; Ya-Chung Tian; Chih-Wei Yang; Gerard F Anderson; Lai-Chu See
Journal:  J Clin Med       Date:  2020-11-06       Impact factor: 4.241

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.